bf/NASDAQ:MITO_icon.jpeg

COM:STEALTHBT

Stealth BioTherapeutics

  • Stock

USD

Last Close

0.32

15/11 21:00

Volume Today

1.30M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Jun '20
Sep '20
Dec '20
Dec '21
net income
-22.07M
-
-26.59M
20.48%
3.73M
114.03%
-12.37M
431.61%
-11.21M
9.37%
-18.34M
63.59%
-10.61M
42.14%
depreciation and amortization
84.81K
-
73.92K
12.84%
76K
2.81%
42K
-
35K
16.67%
deferred income tax
stock based compensation
309.33K
-
320.87K
3.73%
923K
187.65%
1.11M
-
3.07M
176.15%
change in working capital
1.90M
-
-81.74K
104.31%
423K
617.51%
-989K
-
203K
120.53%
786K
287.19%
accounts receivables
inventory
accounts payables
2.86M
-
2.20M
23.32%
2.24M
1.80%
61K
-
-120K
296.72%
other working capital
-968.72K
-
-2.28M
135.17%
-1.81M
20.42%
142K
-
906K
538.03%
other non cash items
1.31M
-
5.11M
290.19%
177K
96.54%
12.37M
6,888.14%
12.20M
1.37%
7.26M
40.45%
-28.53M
492.75%
net cash provided by operating activities
-18.47M
-
-21.16M
14.59%
5.33M
125.18%
-9.72M
-
-35.25M
262.81%
investments in property plant and equipment
-20K
-
-47K
135%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
-33.49K
-
250K
-
net cash used for investing activites
-33.49K
-
-20K
-
203K
1,115%
debt repayment
-711K
-
-1K
-
-1K
0%
common stock issued
9.79M
-
2.76M
-
-2.76M
200%
common stock repurchased
dividends paid
other financing activites
27.94M
-
-872K
103.12%
19.87M
-
39.27M
97.65%
net cash used provided by financing activities
27.94M
-
8.21M
70.62%
22.63M
-
36.51M
61.31%
effect of forex changes on cash
12.89M
-
net change in cash
-18.50M
-
6.78M
136.63%
13.54M
99.77%
12.89M
-
14.35M
11.28%
cash at beginning of period
22.62M
-
4.08M
81.97%
37.23M
812.88%
19.89M
-
32.79M
64.82%
cash at end of period
4.12M
-
10.86M
163.55%
50.77M
367.69%
32.79M
-
47.13M
43.76%
operating cash flow
-18.47M
-
-21.16M
14.59%
5.33M
125.18%
-9.72M
-
-35.25M
262.81%
capital expenditure
-20K
-
-47K
135%
free cash flow
-18.47M
-
-21.16M
14.59%
5.33M
125.18%
-9.74M
-
-35.30M
262.54%

All numbers in USD (except ratios and percentages)